Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 1 medicine
AEMPS · 1 medicine
AIFA · 1 medicine
CBG-MEB · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cleviprex | United States | 125MG/250ML, 25MG/50ML, 50MG/100ML | emulsion | Marketed | Chiesi |
| Cleviprex | Italy | Emulsione iniettabile | Authorised | Chiesi Farmaceutici S.P.A. | |
| Cleviprex | Canada | 0.5 MG / ML | Emulsion | Marketed | Chiesi Farmaceutici S.P.A. |
| Cleviprex 0,5MG/ML Emulsion Inyectable | Spain | 0,5 mg | emulsion inyectable | Marketed | Chiesi España S.A.U. |
| Cleviprex 0,5 mg/ml, emulsie voor injectie | Netherlands | Emulsie voor injectie | Authorised | Chiesi Pharmaceuticals B.V. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, FDA and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
